# Auditory MMN EEG in TRD in Response to Ketamine

> **NCT05464264** · — · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 30 (estimated)

## Conditions studied

- Treatment-resistant Depression (TRD)

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT05464264
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-03
- **Primary completion:** 2024-10
- **Final completion:** 2024-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05464264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05464264, "Auditory MMN EEG in TRD in Response to Ketamine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05464264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*